Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)

Clinical trial NCT04739202 · COMPLETED

Trial details

NCT number: NCT04739202
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Metastatic Gastric Cancer Metastatic Adenocarcinoma Advanced Gastric Carcinoma

Start date: 2021-03-19
Primary completion: 2026-06-04
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.